MBD3L4: A Potential Drug Target for Various Diseases (G653656)

Target Name: MBD3L4

NCBI ID: G653656

MBD3L4

MBD3L4: A Potential Drug Target for Various Diseases

MBD3L4, also known as MB3L4, is a protein that is expressed in various tissues of the human body. It is a member of the myostatin family, which is known for its role in regulating muscle growth and maintenance. MBD3L4 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, MBD3L4 has become a promising drug target for researchers to explore for new treatments.

One of the key features of MBD3L4 is its ability to interact with several different signaling pathways. This makes it a potentially versatile drug target, as researchers can target different aspects of the MBD3L4 protein to different effects. One of the most promising aspects of MBD3L4 is its role in the development and progression of cancer.

Studies have shown that MBD3L4 is highly expressed in various types of cancer, including breast, ovarian, and prostate cancer. It has also been shown to play a role in the regulation of cell signaling pathways that are often disrupted in cancer cells. For example, studies have shown that MBD3L4 can interact with the TGF-β pathway, which is a well-established pathway that is involved in cancer cell growth and survival.

In addition to its role in cancer development, MBD3L4 has also been shown to be involved in the regulation of cellular processes that are important for maintaining tissue homeostasis. This includes the regulation of cell migration and the maintenance of cell-cell adhesion, which are critical for the proper functioning of tissues.

Another promising aspect of MBD3L4 is its role in neurodegenerative diseases. Studies have shown that MBD3L4 is involved in the regulation of the neurotransmitter GDPJ, which is involved in the regulation of neurotransmitter release and uptake. This suggests that MBD3L4 may play a role in the development and progression of neurodegenerative diseases.

MBD3L4 has also been shown to be involved in the regulation of autoimmune disorders. Studies have shown that MBD3L4 is involved in the regulation of the cytokine environment, which is a critical factor in the regulation of immune responses. This suggests that MBD3L4 may play a role in the development and progression of autoimmune disorders.

In conclusion, MBD3L4 is a protein that has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, MBD3L4 has become a promising drug target for researchers to explore for new treatments. Further research is needed to fully understand the role of MBD3L4 in these diseases and to develop effective treatments.

Protein Name: Methyl-CpG Binding Domain Protein 3 Like 4

The "MBD3L4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MBD3L4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets